Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Clinical trial NCT00325130 · COMPLETED

Trial details

NCT number: NCT00325130
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Glandular and Epithelial Diphtheria Tetanus Whooping Cough Meningitis

Start date: 2006-04-01
Primary completion: 2007-04-01
Enrollment: 1042

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.